4th Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues, including: 340B program; TRICARE Pharmacy Program; FDA Guidance on Alzheimer's drug development; Pharmaceutical Supply Chain; Drug Pricing; PDUFA Reauthorization; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7667 (117th), S. 4348 (117th), S. 920 (117th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Proposed Part B IPI Demonstration Project; Drug Pricing; CMS NCD for Alzheimer's Drugs; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.4479/S.2609, Facilitating Innovative Nuclear Diagnostics Act of 2021; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), H.R. 748 (117th), S. 2609 (117th), H.R. 1319 (117th), H.R. 4479 (117th)

Trade (domestic/foreign) TRD

Issues related to pharmaceutical IP and supply chain.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to R&D tax credit; FY2023 Consolidated Appropriations Act (H.R.2617).

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
MATHEW LAPINSKI —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2617 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.